NCT04081597View on ClinicalTrials.gov

A Study of Single Ascending Doses of STAR-101 in Healthy Participants

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 29, 2020

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Star-101

Administered orally

DRUG

Placebo

Administered orally

Sponsors
All Listed Sponsors
lead

Acanthas Pharma Inc

INDUSTRY

NCT04081597 - A Study of Single Ascending Doses of STAR-101 in Healthy Participants | Biotech Hunter | Biotech Hunter